超聲內(nèi)鏡對(duì)食管胃底靜脈曲張?jiān)\斷價(jià)值及與多層螺旋CT血管造影診斷比較
發(fā)布時(shí)間：2018-12-20 05:43
【摘要】：目的1.分析肝硬化及慢性乙型肝炎(chronic viral hepatitis B,CHB)患者超聲內(nèi)鏡(endoscopic ultrasonography,EUS)下胃底食管靜脈曲張(esophageal and gastric varices,EGV)各部位檢出情況,評(píng)估EUS對(duì)EGV的早期診斷價(jià)值。通過EUS對(duì)于入組患者進(jìn)行隨訪,了解EGV變化,評(píng)估預(yù)后。2.探討EUS與門脈CT血管造影(Computed Tomography Angiography,CTA)在肝硬化患者EGV診斷方面的一致性。方法1.采用EUS對(duì)116例胃鏡下未見EGV的乙肝后肝硬化患者及182例CHB患者進(jìn)行檢測(cè),按照曲張靜脈的部位及程度進(jìn)行分級(jí),分析兩組患者食管胃底各部位靜脈曲張及穿通支的檢出情況。2.肝硬化組按照Child-Pugh分級(jí)分成3組,CHB組按照是否抗病毒治療分為2組,1年后對(duì)所有入組患者復(fù)查EUS,分析隨訪前后EGV變化情況。3.選取84例肝硬化患者做為研究對(duì)象,總結(jié)EUS及CTA對(duì)食管胃底粘膜下及外周靜脈曲張檢出情況,比較兩者診斷方面的一致性。結(jié)果1.肝硬化組中,101例患者可檢出多于一個(gè)部位的胃食管外周靜脈曲張,68例患者可檢出兩個(gè)以上部位胃食管外周靜脈曲張,21例患者同時(shí)檢出食管黏膜下及食管外周靜脈曲張,30例患者可同時(shí)檢出胃底粘膜下及胃底外周靜脈曲張。2.肝硬化組與CHB組相比,食管及胃底黏膜下靜脈曲張、食管及胃底旁靜脈曲張、食管及胃底周圍靜脈曲張檢出情況差異均有統(tǒng)計(jì)學(xué)意義(P0.05)。兩組患者穿通支檢出情況相比,差異有統(tǒng)計(jì)學(xué)意義(P0.05)。3.1年后再次復(fù)查EUS,肝硬化患者中,68例Child A級(jí)患者各部位靜脈曲張未見明顯變化,6例患者靜脈曲張消退或減輕,1例患者由Child A級(jí)進(jìn)展為Child C級(jí)。8例Child B級(jí)患者靜脈曲張程度加重,5例患者發(fā)現(xiàn)新的靜脈曲張。4例Child C級(jí)患者靜脈曲張程度加重,2例患者發(fā)現(xiàn)新的靜脈曲張。4.HBV抗病毒組,23例靜脈曲張程度減輕或消退。未抗病毒組,4例患者靜脈曲張程度加重,6例患者出現(xiàn)新發(fā)靜脈曲張,1例患者進(jìn)展為肝硬化Child A級(jí)。5.EUS與門脈CTA相比,對(duì)于食管黏膜下靜脈曲張檢出不具有高度一致性(P0.05)。對(duì)于食管外周靜脈、胃底黏膜下靜脈及胃底外周靜脈,EUS與門脈CTA在靜脈曲張檢出率方面具有高度一致性(P0.05)。結(jié)論1.對(duì)于在胃鏡下未見到靜脈曲張的肝硬化及CHB群體而言,EUS可以發(fā)現(xiàn)食管胃底黏膜下靜脈曲張及外周靜脈曲張,對(duì)更早期診斷肝硬化及區(qū)分病情程度具有意義。2.抗病毒治療可以延緩肝硬化靜脈曲張的進(jìn)展,通過抗病毒治療可使部分早期肝纖維化患者靜脈曲張得到一定程度逆轉(zhuǎn)。但對(duì)于Child B-C級(jí)患者,即使進(jìn)行抗病毒治療,仍然不能完全阻止靜脈曲張加重。3.未抗病毒治療的CHB患者,可出現(xiàn)新發(fā)EGV或者EGV加重,甚至快速進(jìn)展為肝硬化。4.抗病毒治療的CHB患者EGV大多數(shù)無變化,極少數(shù)患者出現(xiàn)病情進(jìn)展。5.監(jiān)測(cè)EUS變化對(duì)于評(píng)估慢性肝病患者病情進(jìn)展及預(yù)后具有一定臨床意義。6.EUS對(duì)于食管黏膜下靜脈曲張檢出率比門脈CTA更高。EUS與門脈CTA對(duì)于食管外周靜脈曲張、胃底黏膜下靜脈靜脈曲張及胃底外周靜脈靜脈曲張的檢出率高度一致。
[Abstract]:Purpose 1. To evaluate the value of EUS on the early diagnosis of esophageal varices (EGV) in patients with liver cirrhosis and chronic hepatitis B (CHB). EUS was followed up for enrolled patients to understand the changes in EGV and to assess the prognosis. To study the consistency of EUS and gated CT angiography (CTA) in the diagnosis of liver cirrhosis. Method 1. EUS was used to test 116 patients with liver cirrhosis and 182 patients with CHB who had not seen EGV in 116 cases of gastroscope. The liver cirrhosis group was divided into 3 groups according to the Child-Pugh classification, and the CHB group was divided into two groups according to whether the anti-virus treatment was performed. After 1 year, the EUS was reexamined for all the enrolled patients, and the change of EGV before and after follow-up was analyzed. Eighty-four patients with liver cirrhosis were selected as the subject of the study, and the results of EUS and CTA on the detection of the submucosal and peripheral varices of the esophagus and the submucous membrane of the esophagus were summarized. Results 1. In the group of liver cirrhosis, in 101 patients, more than one part of the gastric oesophageal varices were detected, and in 68 patients, more than two parts of the gastric oesophageal varices were detected. In 21 patients, the esophageal mucosa and the esophageal varices were detected at the same time, and 30 patients were able to detect both the submucosal and the bottom of the stomach at the same time. weekly varices. There was a significant difference in the detection of the varices of the esophagus and the submucous membrane of the stomach, the varices of the esophagus and the bottom of the stomach, the esophageal and the perigastric varices in the group of liver cirrhosis and the group of CHB (P0.05). The difference between the two groups was statistically significant (P0.05). After 1 year, EUS was re-examined. In the patients with liver cirrhosis, there were no significant changes in the varicose veins in 68 patients with Child A, 6 cases of varicosis or reduction of varicosity in 6 cases, and 1 case with Child-A progression to Child C. 8 patients with Child B grade increased varicosity, 5 patients found a new varicose vein. 4 cases of Child C grade patient's vein The degree of tension increased, and 2 patients found a new varicose vein. 4. The anti-virus group of HBV and 23 cases of varicosity were reduced or resolved. No anti-virus group, 4 patients with varicose veins increased, 6 patients had a new varicosity, 1 patient progressed to Child A grade of cirrhosis, and 5. EUS did not have a high degree of consistency in the detection of varicose veins in the esophageal mucosa (P0.05). For the peripheral vein of the esophagus, the lower submucosal vein of the stomach and the peripheral vein of the bottom of the stomach, the EUS and the gate vein CTA had a high degree of consistency in the detection rate of the varicosity (P0.05). Conclusion 1. EUS can find esophageal and gastric submucosal varicose veins and peripheral varices for cirrhosis and CHB group without varicosity under gastroscope. The anti-virus therapy can delay the development of the cirrhosis of the liver cirrhosis, and the varicose veins of the patients with early hepatic fibrosis can be reversed to a certain degree by the anti-virus treatment. However, for Child B-C patients, it is still not possible to completely block varicose veins even if antiviral therapy is performed. In patients with CHB without anti-viral treatment, new EGV or EGV exacerbation may occur, even with rapid progression to cirrhosis. The majority of the patients with CHB in the anti-viral treatment did not change, and a very small number of patients had a disease progression. The monitoring of EUS changes has a certain clinical significance for assessing the progress and prognosis of patients with chronic liver disease. EUS and gate-vein CTA were highly consistent with the rate of varicose veins of the esophagus, the varicose veins of the submucous membrane of the stomach and the varicose veins of the peripheral veins of the bottom of the stomach.
【學(xué)位授予單位】：天津醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R575.2
本文編號(hào)：2387516
[Abstract]:Purpose 1. To evaluate the value of EUS on the early diagnosis of esophageal varices (EGV) in patients with liver cirrhosis and chronic hepatitis B (CHB). EUS was followed up for enrolled patients to understand the changes in EGV and to assess the prognosis. To study the consistency of EUS and gated CT angiography (CTA) in the diagnosis of liver cirrhosis. Method 1. EUS was used to test 116 patients with liver cirrhosis and 182 patients with CHB who had not seen EGV in 116 cases of gastroscope. The liver cirrhosis group was divided into 3 groups according to the Child-Pugh classification, and the CHB group was divided into two groups according to whether the anti-virus treatment was performed. After 1 year, the EUS was reexamined for all the enrolled patients, and the change of EGV before and after follow-up was analyzed. Eighty-four patients with liver cirrhosis were selected as the subject of the study, and the results of EUS and CTA on the detection of the submucosal and peripheral varices of the esophagus and the submucous membrane of the esophagus were summarized. Results 1. In the group of liver cirrhosis, in 101 patients, more than one part of the gastric oesophageal varices were detected, and in 68 patients, more than two parts of the gastric oesophageal varices were detected. In 21 patients, the esophageal mucosa and the esophageal varices were detected at the same time, and 30 patients were able to detect both the submucosal and the bottom of the stomach at the same time. weekly varices. There was a significant difference in the detection of the varices of the esophagus and the submucous membrane of the stomach, the varices of the esophagus and the bottom of the stomach, the esophageal and the perigastric varices in the group of liver cirrhosis and the group of CHB (P0.05). The difference between the two groups was statistically significant (P0.05). After 1 year, EUS was re-examined. In the patients with liver cirrhosis, there were no significant changes in the varicose veins in 68 patients with Child A, 6 cases of varicosis or reduction of varicosity in 6 cases, and 1 case with Child-A progression to Child C. 8 patients with Child B grade increased varicosity, 5 patients found a new varicose vein. 4 cases of Child C grade patient's vein The degree of tension increased, and 2 patients found a new varicose vein. 4. The anti-virus group of HBV and 23 cases of varicosity were reduced or resolved. No anti-virus group, 4 patients with varicose veins increased, 6 patients had a new varicosity, 1 patient progressed to Child A grade of cirrhosis, and 5. EUS did not have a high degree of consistency in the detection of varicose veins in the esophageal mucosa (P0.05). For the peripheral vein of the esophagus, the lower submucosal vein of the stomach and the peripheral vein of the bottom of the stomach, the EUS and the gate vein CTA had a high degree of consistency in the detection rate of the varicosity (P0.05). Conclusion 1. EUS can find esophageal and gastric submucosal varicose veins and peripheral varices for cirrhosis and CHB group without varicosity under gastroscope. The anti-virus therapy can delay the development of the cirrhosis of the liver cirrhosis, and the varicose veins of the patients with early hepatic fibrosis can be reversed to a certain degree by the anti-virus treatment. However, for Child B-C patients, it is still not possible to completely block varicose veins even if antiviral therapy is performed. In patients with CHB without anti-viral treatment, new EGV or EGV exacerbation may occur, even with rapid progression to cirrhosis. The majority of the patients with CHB in the anti-viral treatment did not change, and a very small number of patients had a disease progression. The monitoring of EUS changes has a certain clinical significance for assessing the progress and prognosis of patients with chronic liver disease. EUS and gate-vein CTA were highly consistent with the rate of varicose veins of the esophagus, the varicose veins of the submucous membrane of the stomach and the varicose veins of the peripheral veins of the bottom of the stomach.
【學(xué)位授予單位】：天津醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R575.2
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 李瑞雄;楊維珍;蔣仕伍;;多層螺旋CT血管造影在肝硬化血管改變及側(cè)支循環(huán)中的應(yīng)用價(jià)值[J];中國臨床新醫(yī)學(xué);2015年10期
2 尚瑞蓮;孫自勤;賈愛芹;李群;魏志;孫奎林;劉曉峰;;超聲內(nèi)鏡引導(dǎo)下硬化劑注射對(duì)食管靜脈曲張?zhí)自g(shù)后殘留曲張靜脈及穿通支序貫治療的觀察[J];解放軍醫(yī)學(xué)雜志;2014年07期
3 劉文娜;郝婷婷;王劍;寧濤;謝元元;馮義朝;戴光榮;;64層螺旋CT門靜脈造影對(duì)肝硬化患者肝功能分級(jí)和食管靜脈曲張破裂出血的預(yù)測(cè)價(jià)值[J];實(shí)用肝臟病雜志;2014年03期
4 李偉;;多層螺旋CT門靜脈成像評(píng)估肝硬化食管靜脈曲張出血風(fēng)險(xiǎn)[J];胃腸病學(xué)和肝病學(xué)雜志;2013年12期
5 李焱;孫長宇;周言;;非侵入性指標(biāo)診斷肝硬化食管靜脈曲張的價(jià)值[J];鄭州大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2013年04期
6 韓笑;麻樹人;;急診內(nèi)鏡下套扎治療食管靜脈曲張破裂出血361例療效分析[J];中國實(shí)用內(nèi)科雜志;2013年04期
7 李麥福;陳廣禮;;16層螺旋CTA對(duì)原發(fā)性肝癌介入治療的臨床應(yīng)用價(jià)值[J];中國CT和MRI雜志;2012年05期
8 李妙玲;趙婷婷;袁會(huì)軍;孫興旺;強(qiáng)永乾;;64排螺旋CT血管造影評(píng)價(jià)肝硬化血管改變及側(cè)支循環(huán)[J];中國醫(yī)學(xué)影像技術(shù);2011年09期
9 秦將均;涂蓉;巫北海;俞安樂;王正文;伍保忠;;胃左靜脈的多層螺旋CT評(píng)價(jià)對(duì)預(yù)測(cè)食管靜脈曲張出血風(fēng)險(xiǎn)的價(jià)值[J];實(shí)用放射學(xué)雜志;2011年09期
10 賈玉良;韓真;黃月娥;王運(yùn)東;何池義;袁鶴鳴;張國政;;進(jìn)展期殘胃癌29例內(nèi)鏡和內(nèi)鏡超聲分析[J];中華全科醫(yī)學(xué);2011年08期
相關(guān)碩士學(xué)位論文 前2條
1 宋兵;胃左靜脈MSCTA與肝硬化相關(guān)性研究[D];河北醫(yī)科大學(xué);2011年
2 解天華;門靜脈高壓不同側(cè)枝循環(huán)特征的臨床意義研究[D];山東大學(xué);2009年
，本文編號(hào)：2387516
本文鏈接：http://www.wukwdryxk.cn/yixuelunwen/xiaohjib/2387516.html
最近更新
教材專著
